DPY19L2P4: A Potential Drug Target and Biomarker (G442523)

Target Name: DPY19L2P4

NCBI ID: G442523

Other Name(s): DPY19L2 pseudogene 4

DPY19L2P4: A Potential Drug Target and Biomarker

DPY19L2P4 is a gene located on chromosome 19q17.1 in the database ENCODE (Encyclopedia of DNA Elements). It is a pseudogene, which means that it is a stretch of DNA that has the potential to encode a functional gene but has not yet been proven . Research has identified several potential drug targets and biomarkers associated with the DPY19L2P4 gene.

One of the potential drug targets associated with DPY19L2P4 is the protein p16INK4a. p16INK4a is a post-transcriptionally modified nucleolar protein that can phosphorylate and activate the DPY19L2P4 gene. Studies have shown that the phosphorylation level of p16INK4a is directly proportional to the expression level of the DPY19L2P4 gene, indicating that p16INK4a may be a good drug target.

Another potential drug target is the protein DPY19L2P4 encoded by the DPY19L2P4 gene. DPY19L2P4 is a serine protein kinase (SPK) that participates in cell signaling in cells. Studies have shown that the phosphorylation level of DPY19L2P4 protein is directly proportional to the level of p16INK4a in cells, indicating that the DPY19L2P4 protein may also be a drug target.

DPY19L2P4 is also closely related to the occurrence and development of some diseases. For example, mutations in the DPY19L2P4 gene are associated with the development of various cancers, including liver cancer, breast cancer, and kidney cancer. Studies have shown that DPY19L2P4 gene expression levels are related to the survival rates of patients with various cancers, indicating that DPY19L2P4 may also be an important biomarker.

DPY19L2P4 is an interesting gene with multiple functions and potential drug targets. Future studies will continue to study DPY19L2P4 in depth and determine its potential as a drug target or biomarker.

Protein Name: DPY19L2 Pseudogene 4

More Common Targets